| ²é¿´: 10687 | »Ø¸´: 193 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
FDA¹¤ÒµÖ¸ÄÏ--CGMPµÄÖÊÁ¿Ìåϵ(ÖÐÓ¢ÎÄ£©
|
||
|
·ÖΪÁ½¸ö²¿·Ö µÚÒ»²¿·Ö FDA¹¤ÒµÖ¸ÄÏ--CGMPµÄÖÊÁ¿Ìåϵ(ÖÐÎÄÒë¸å£© µÚ¶þ²¿·Ö Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations ±¾Ö¸ÄÏ´ú±íÁËFDA¶ÔÖÊÁ¿Ìåϵµ±Ç°µÄ˼¿¼¡£Ëü¼ÈûÓÐΪÈκÎÈËÒ²²»ÊÇΪ¸³ÓèÈκÎÈËÀûÒæ¶øÖƶ¨¡£²¢ÇÒÆä²Ù×÷Ò²²»¶ÔFDA»ò¹«ÖÚÐγÉÔ¼Êø¡£Ö»ÒªÄܹ»Âú×ã¶ÔÏÖÐз¨¹æºÍ¹æ·¶µÄÒªÇóÄã¿ÉÒÔ²ÉÓÃÆäËü·½·¨¡£Èç¹ûÄãÓÐÐËȤÌÖÂÛÆäËü·½·¨£¬¿ÉÒÔÁªÏµ¸ºÔðÖ´Ðб¾Ö¸ÄϵÄFDAÈËÔ±¡£Èç¹ûÄãÎÞ·¨È·ÈÏÇ¡µ±µÄFDAÈËÔ±£¬¿ÉÒÔ²¦´ò±¾Ö¸ÄϹ«²¼µÄµç»° |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
µ÷¼Á
ÒѾÓÐ3È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ264È˻ظ´
»ªÀíҩѧѧ˶Çóµ÷¼Á£¬×Ü·Ö324
ÒѾÓÐ0È˻ظ´
26Ä격ʿÉêÇë
ÒѾÓÐ20È˻ظ´
ÇóÖú ±½Á×Áò°·JP
ÒѾÓÐ0È˻ظ´
100½ð±Ò °¢ÄªÎ÷ÁÖ¿ËÀάËá¼ØÆ¬BPÒ©µäÖÐÌáµ½µÄ¿ËÀάËá¾ÛºÏÎï¾ßÌå½á¹¹Ê½ÊÇɶ£¿
ÒѾÓÐ2È˻ظ´
°ÄÃÅÀí¹¤´óѧÈ˹¤ÖÇÄÜÒ©Îï·¢ÏÖÖÐÐÄÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ10È˻ظ´
ÉÅʳ²¹³ä¼ÁºÏ¹æÐÔ½»Á÷
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸Õã´óҩѧÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
¸ßθßѹ·´Ó¦ÇóÖú
ÒѾÓÐ4È˻ظ´
102Â¥2013-11-21 12:48:35
¼òµ¥»Ø¸´
qwliu2Â¥
2011-05-16 13:22
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
sigmax3Â¥
2011-05-16 13:51
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
zmjxlp9324Â¥
2011-05-16 22:45
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
zmjxlp9325Â¥
2011-05-16 22:45
»Ø¸´
¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
leawell6Â¥
2011-05-17 10:17
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
leawell7Â¥
2011-05-17 10:18
»Ø¸´
¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
sqz9208Â¥
2011-05-17 10:27
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
dhjjjy9Â¥
2011-05-19 13:27
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wanggj12310Â¥
2011-05-20 08:41
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
chonggege11Â¥
2011-05-20 08:56
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
hnzhjg12Â¥
2011-05-23 07:32
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xiaolan13Â¥
2011-05-23 08:43
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
dongmingcx14Â¥
2011-05-24 19:08
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡














»Ø¸´´ËÂ¥
qiuwenjun09
10